Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial

Howard L. Kaufman, Jeffery S. Russell, Omid Hamid, +15

The Lancet Oncology

MedicineMetronomic TherapyPathologyCancer TreatmentOncology +1

Phase I Trial of M7824 (MSB0011359C), a Bifunctional Fusion Protein Targeting PD-L1 and TGFβ, in Advanced Solid Tumors

Julius Strauss, Christopher R. Heery, Jeffrey Schlom, +12

Clinical Cancer Research

Combination Therapy With Telaprevir for Chronic Hepatitis C Virus Genotype 1 Infection in Patients With HIV

Mark Sulkowski, Kenneth E. Sherman, Douglas T. Dieterich, +12

Annals of Internal Medicine

Real-world treatment outcomes in patients with metastatic Merkel cell carcinoma treated with chemotherapy in the USA

C. Lance Cowey, Lisa Mahnke, Janet L. Espirito, +3

Future Oncology

Evaluation of real-world treatment outcomes in patients with distant metastatic Merkel cell carcinoma following second-line chemotherapy in Europe

Jürgen C. Becker, Eva Lorenz, Selma Ugurel, +14

Oncotarget

Clinical drug‐drug interaction assessment of ivacaftor as a potential inhibitor of cytochrome P450 and P‐glycoprotein

Sarah Robertson, Xia Luo, Neeraj Dubey, +5

The Journal of Clinical Pharmacology

Drug InteractionsIvacaftor Indicated IvacaftorDrug AnalysisPharmacological StudyPharmacology +10

Effect of Low-Dose Omeprazole (20 mg Daily) on the Pharmacokinetics of Multiple-Dose Atazanavir With Ritonavir in Healthy Subjects

Li Zhu, Anna Persson, Lisa Mahnke, +6

The Journal of Clinical Pharmacology

Low-dose OmeprazoleHealthy SubjectsMedicineOmeprazole 40Immunology +11

The Effect of Atazanavir/Ritonavir on the Pharmacokinetics of An Oral Contraceptive Containing Ethinyl Estradiol and Norgestimate in Healthy Women

Jenny Zhang, Ellen Chung, Cynthia Yones, +5

Antiviral Therapy

Conserved amino acids of the human immunodeficiency virus type 2 Vpx nuclear localization signal are critical for nuclear targeting of the viral preintegration complex in non-dividing cells

Michael Belshan, Lisa Mahnke, Lee Ratner

Virology

Viral ReplicationHuman RetrovirusAntiviral ResponseMolecular BiologyVirology +7

Abstract CT079: Durable responses to avelumab (anti-PD-L1) in patients with Merkel cell carcinoma progressed after chemotherapy: 1-year efficacy update

Howard L. Kaufman, Jeffery S. Russell, Omid Hamid, +12

Cancer Research

Cancer ManagementImmunologyPathologyDermatologyMetastatic Mcc +17